Device Access

Established in 2010, Device Access has supported over 40 successful applications for NICE approvals and more than 1000 cases for change within the NHS, prior to joining the IGES group in 2019. Device Access has supported a wide range of international and European companies introducing high value medical technologies to the UK, effectively navigating the complex NHS reimbursement pathways through the creation and implementation of local and national market access strategies that demonstrate the technologies’ true value. In 2017, Device Access became one of the first NICE approved facilitators for the MedTech Early Technical Assessment (META Tool®). Device Access holds a data sharing agreement from NHS England, which provides data on all hospital admissions and outcomes on a monthly basis, allowing them to work with companies to further understand the impact technologies may have on current patient populations. As market access consultants, we help you to demonstrate the benefits of your device to patients, care providers and payers through national approvals and recommendations.